Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations with a high degree of accuracy. The study is published in Nature Communicatio ...
Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...
For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a ...
Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations with a high degree of accuracy. The study is published in Nature ...
Hot weather tends to bring out the worst in people, and no one bears the brunt of this more than retail employees. One such worker was just trying to survive her shift when a nightmare customer ...
Please provide your email address to receive an email when new articles are posted on . The annualized exacerbation rate was 3.18 per patient-year before tezepelumab and 1.97 per patient-year after ...
Mepolizumab significantly reduced asthma exacerbations and oral corticosteroid use in patients with SEA, with or without CRSwNP, in a real-world setting. Improvements in lung function and asthma ...
Dr. Harold Nelson answers the question: 'Taking Medicine Without Asthma Attack?' — -- Question: Why do I have to take medicine when I am not having an asthma attack? Answer: The asthma attack is ...
A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the widely-used salbutamol inhaler. The corresponding study was published in The Lancet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results